Analysis of short-term outcomes for lobar lung transplantation
10.3760/cma.j.cn421203-20200224-00046
- VernacularTitle:肺叶移植的早期临床效果分析
- Author:
Guilin PENG
1
;
Chao YANG
;
Mengyang LIU
;
Weixue CUI
;
Chunrong JU
;
Bing WEI
;
Jianxing HE
;
Xin XU
Author Information
1. 广州医科大学附属第一医院胸外科 器官移植科 510120
- From:
Chinese Journal of Organ Transplantation
2020;41(6):333-336
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical value of lobar lung transplantation for end-stage lung disease patients in organ donation era.Methods:Clinical data were analyzed retrospectively for 14 cases with lobar lung transplantations between January 2016 and December 2019, including clinical outcomes and postoperative complications.Results:Eleven cases(78.6 %)had a positive etiology examination in bronchial secretion or tissue culture. There were unilateral lobar lung transplantation (n=2), bilateral lobar lung transplantation(n=2)and unilateral lobar lung transplantation and contralateral lung transplantation(n=10). Intra-operative ECMO(n=11)postoperative ECMO(n=5)were required. All survived during a 30-day perioperative period. The median time of postoperative ECMO was 1(1~11)day, the median time of extubation 4.5(0~182)day and the median time of stay in ICU 11(2~186)day. Re-operation was required for 1 case due to active bleeding in thoracic cavity. There were 10 survivors and 4 deaths. The causes of death were bronchus fistula(n=2), pulmonary infection(n=1)and renal failure(n=1)respectively.Conclusions:Lobar lung transplantation is efficacious for selected patients with end-stage lung disease.
